The Senate Health, Education, Labor and Pensions Committee has advanced the nomination of Dr. Erica Schwartz to become the 22nd director of the Atlanta-based Centers for Disease Control and Prevention (CDC). If confirmed by the full Senate, the 54-year-old Schwartz will lead the agency charged with protecting Americans from preventable health threats.

Schwartz’s background includes medical and law degrees, a previous role as deputy surgeon general, and leadership experience within the U.S. public health system. However, her confirmation hearing earlier this month revealed doubts among some senators about her willingness to resist political interference, particularly from President Trump's health secretary, Robert F.

Republican Senator Bill Cassidy of Louisiana initially questioned Schwartz’s independence but later stated he had spoken with her and others familiar with her work, expressing confidence in her qualifications. He noted in a recent interview that Schwartz might rebuild the CDC’s depleted command structure and restore public trust by focusing on bipartisan issues such as foodborne disease outbreaks.

Despite this, the National Public Health Coalition, representing current and former CDC employees, expressed dissatisfaction with Schwartz’s responses during the hearing. The group urged senators to demand specific written commitments from her on scientific independence, evidence-based vaccine policies, and conflict-of-interest safeguards. They criticized her answers as often incomplete, vague, or missing, emphasizing the public’s need for clear assurances that CDC guidance will be protected from political pressure.

The nomination advances amid ongoing debates about the agency’s direction and leadership. Schwartz’s confirmation would follow a canceled Senate hearing in March 2025 for another nominee, highlighting the challenges in filling the CDC’s top role.

Sources